Cantourage Group Past Earnings Performance
Past criteria checks 4/6
Cantourage Group has been growing earnings at an average annual rate of 329.1%, while the Pharmaceuticals industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 175.6% per year. Cantourage Group's return on equity is 0.09%, and it has net margins of 2.3%.
Key information
329.1%
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals Industry Growth | 7.3% |
| Revenue growth rate | 175.6% |
| Return on equity | 0.09% |
| Net Margin | 2.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Cantourage Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2 | 0 | 1 | 0 |
| 30 Sep 23 | 1 | 0 | 1 | 0 |
| 30 Jun 23 | 1 | 0 | 0 | 0 |
| 31 Dec 22 | 1 | 0 | 0 | 0 |
| 31 Dec 21 | 5 | -1 | 1 | 0 |
Quality Earnings: HIGH has high quality earnings.
Growing Profit Margin: HIGH's current net profit margins (2.3%) are higher than last year (1.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HIGH has become profitable over the past 5 years.
Accelerating Growth: Insufficient data to compare HIGH's past year earnings growth to its 5-year average.
Earnings vs Industry: HIGH earnings growth over the past year (329.1%) exceeded the Pharmaceuticals industry 1.5%.
Return on Equity
High ROE: HIGH's Return on Equity (0.09%) is considered low.